Outcomes Of The Spanish Cohort Of Early Access To Pertuzumab And Trastuzumab Emtansine
Clinical trial NCT03025711 · COMPLETED
Trial details
- NCT number
- NCT03025711
- Sponsor
- BELEN RUIZ-ANTORAN
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2017-12-01
- Primary completion
- 2018-10-01
- Enrollment
- 220
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.